EverlyWell Stock

At-Home Lab Testing

Sign up today and learn more about EverlyWell Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About EverlyWell Stock

EverlyWell develops do-it-yourself kits for a vast range of at-home regulatory-compliant diagnostic tests including food sensitivity, fertility, hormones, STDs, thyroid, and metabolism among the others, allowing users to perform tests at home and receive physician-reviewed results and insights on their mobile devices.


Funding History

February 2016$3.1M
December 2017$2.4M
December 2017$10.3M
February 2019$30.0M
February 2020$25.0M
November 2020$258M


Chief Executive Officer

Julia Cheek

Chief Financial Officer

Chris Bishko

Chief Technology Officer

Nick Parker


mobihealthnews - Mar, 25 2021

Home Access Health Corporation

massdevice - Dec, 4 2020

Everlywell raises $175M

bit - Aug, 10 2020

Healthcare Pandemic Roundup

telegraphindia - May, 19 2020

At-home self-test kit in US

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: